| - GRCh37:
- Chr2:233680385
- GRCh38:
- Chr2:232815675
| GIGYF2 | T737A, T710A, T716A | Parkinson disease 11, autosomal dominant, susceptibility to | Uncertain significance (Jun 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:233684655
- GRCh38:
- Chr2:232819945
| GIGYF2 | E830V, E851V, E824V | Parkinson disease 11, autosomal dominant, susceptibility to | Uncertain significance (Mar 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:233660846
- GRCh38:
- Chr2:232796136
| GIGYF2 | | not provided, Parkinson disease 11, autosomal dominant, susceptibility to | Benign (Jun 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233712296
- GRCh38:
- Chr2:232847586
| GIGYF2 | | not provided, Parkinson disease 11, autosomal dominant, susceptibility to | Benign (Jun 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233712248
- GRCh38:
- Chr2:232847538
| GIGYF2 | | not provided, Parkinson disease 11, autosomal dominant, susceptibility to | Benign (Jun 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233712227-233712229
- GRCh38:
- Chr2:232847517-232847519
| GIGYF2 | Q1216del, Q1237del, Q1210del | not provided | Benign (Jun 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:233712049
- GRCh38:
- Chr2:232847339
| GIGYF2 | | not provided, Parkinson disease 11, autosomal dominant, susceptibility to | Benign (Jun 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233708806
- GRCh38:
- Chr2:232844096
| GIGYF2 | | not provided, Parkinson disease 11, autosomal dominant, susceptibility to | Benign (Mar 3, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233712226-233712227
- GRCh38:
- Chr2:232847515-232847516
| GIGYF2 | Q1211fs, Q1205fs, Q1232fs | not specified, not provided, Parkinson disease 11, autosomal dominant, susceptibility to
| Benign/Likely benign (Jun 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:233684544
- GRCh38:
- Chr2:232819834
| GIGYF2 | A793V, A814V, A787V | Parkinson disease 11, autosomal dominant, susceptibility to, not provided | Conflicting interpretations of pathogenicity (Sep 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:233656136
- GRCh38:
- Chr2:232791426
| GIGYF2 | K421R, K415R, K442R | Parkinson disease 11, autosomal dominant, susceptibility to | risk factor (Sep 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:233655527
- GRCh38:
- Chr2:232790817
| GIGYF2 | I278V, I272V, I300V | Parkinson disease 11, autosomal dominant, susceptibility to | risk factor (Apr 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr2:233674441
- GRCh38:
- Chr2:232809731
| GIGYF2 | D606E, D627E, D600E | Parkinson disease 11, autosomal dominant, susceptibility to | risk factor (Apr 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr2:233659545
- GRCh38:
- Chr2:232794835
| GIGYF2 | N457T, N451T, N478T | Parkinson disease 11, autosomal dominant, susceptibility to | risk factor (Aug 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:233612450
- GRCh38:
- Chr2:232747740
| GIGYF2 | N56S | not specified | Uncertain significance (Oct 17, 2023) | criteria provided, single submitter |